Trials / Completed
CompletedNCT03494140
Viscontour® Serum Med in Hydration of Facial Skin
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- TRB Chemedica AG · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to confirm the clinical safety and efficacy of Viscontour® Serum Med in the hydration of facial tissue.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Viscontour® Serum Med | Viscontour® Serum Med is a CE-certified preservative-free isotonic solution containing 5.0 mg sodium hyaluronate. |
Timeline
- Start date
- 2018-04-18
- Primary completion
- 2018-08-18
- Completion
- 2018-08-18
- First posted
- 2018-04-11
- Last updated
- 2018-09-18
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03494140. Inclusion in this directory is not an endorsement.